1. Home
  2. SPT vs EVO Comparison

SPT vs EVO Comparison

Compare SPT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPT
  • EVO
  • Stock Information
  • Founded
  • SPT 2010
  • EVO 1993
  • Country
  • SPT United States
  • EVO Germany
  • Employees
  • SPT N/A
  • EVO N/A
  • Industry
  • SPT Computer Software: Prepackaged Software
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPT Technology
  • EVO Health Care
  • Exchange
  • SPT Nasdaq
  • EVO Nasdaq
  • Market Cap
  • SPT 799.3M
  • EVO 1.2B
  • IPO Year
  • SPT 2019
  • EVO 2021
  • Fundamental
  • Price
  • SPT $14.37
  • EVO $3.64
  • Analyst Decision
  • SPT Buy
  • EVO Buy
  • Analyst Count
  • SPT 10
  • EVO 2
  • Target Price
  • SPT $27.70
  • EVO $5.40
  • AVG Volume (30 Days)
  • SPT 970.1K
  • EVO 41.3K
  • Earning Date
  • SPT 11-06-2025
  • EVO 11-05-2025
  • Dividend Yield
  • SPT N/A
  • EVO N/A
  • EPS Growth
  • SPT N/A
  • EVO N/A
  • EPS
  • SPT N/A
  • EVO N/A
  • Revenue
  • SPT $430,795,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • SPT $13.01
  • EVO $0.39
  • Revenue Next Year
  • SPT $11.79
  • EVO $9.53
  • P/E Ratio
  • SPT N/A
  • EVO N/A
  • Revenue Growth
  • SPT 14.79
  • EVO N/A
  • 52 Week Low
  • SPT $13.33
  • EVO $2.84
  • 52 Week High
  • SPT $36.30
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • SPT 43.06
  • EVO 52.36
  • Support Level
  • SPT $13.80
  • EVO $3.43
  • Resistance Level
  • SPT $15.56
  • EVO $3.55
  • Average True Range (ATR)
  • SPT 0.66
  • EVO 0.08
  • MACD
  • SPT 0.03
  • EVO 0.04
  • Stochastic Oscillator
  • SPT 33.06
  • EVO 80.00

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: